PS
RDY icon

Principal Securities’s Dr. Reddy's Laboratories RDY Stock Holding History

Principal Securities’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-161
Closed -$2.25K – 3027
2025
Q3 		$2.25K Sell
161
-27
-14% -$389 ﹤0.01% 3199
2025
Q2 		$2.83K Buy
188
+88
+88% +$1.26K ﹤0.01% 3037
2025
Q1 		$1.58K Hold
100
– – ﹤0.01% 3099
2024
Q4 		$1.58K Sell
100
-20
-17% -$300 ﹤0.01% 3093
2024
Q3 		$1.91K Buy
120
+25
+26% +$402 ﹤0.01% 2966
2024
Q2 		$1.45K Buy
95
+10
+12% +$143 ﹤0.01% 2989
2024
Q1 		$1.25K Sell
85
-70
-45% -$1.02K ﹤0.01% 2991
2023
Q4 		$2.16K Buy
+155
New +$2.07K ﹤0.01% 2787

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Principal Securities's RDY Position: Q4 2025 in Review

Principal Securities sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 161 shares — an estimated $2.25K sold.

Principal Securities first reported a position in RDY in Q4 2023 and held it in 8 quarters. The position peaked at $2.83K in Q2 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Principal Securities reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 161 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $2.25K.
  • Principal Securities first reported a position in Dr. Reddy's Laboratories in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Dr. Reddy's Laboratories position peaked at $2.83K in Q2 2025.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.